FDA issues guidance for co-manufacturing supply chains
Guidance sets standards for managing supply chains in co-manufacturing environments
The Food and Drug Administration has released guidance for supply-chain programs in co-manufacturing agreements for the production of human or animal food.
The guidance applies to raw materials and other ingredients for which a receiving facility has identified a hazard requiring a supply-chain-applied control. The guidance does not apply if there are no hazards requiring supply-chain-applied controls in the raw materials or other ingredients used by a co-manufacturer. The guidance applies when the brand owner specifies which suppliers must be used, and there is a hazard that requires a supply-chain-applied control.